ANEB

Anebulo Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website anebulo.com
Employees(FY) 2
ISIN US0345691036

Performance

-28.78%

-34.87%

-52.4%

-51.68%

-59.09%

YTD

-52.86%

Profile

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

Advanced Technical Analysis

Technical Analysis of ANEB 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 3 and the Technical Score at 21, both indicating weak performance. The Oscillators Score at 40 suggests a neutral stance, but overall, the combined scores point to a lack of bullish momentum in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ANEB

Stock Rank

Recent News & Updates

2024-11-13 03:05
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates(Businesswire)
2024-09-25 04:05
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates(Businesswire)
2024-07-21 19:00
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects(Yahoo Finance)
2024-06-30 20:00
Lifecore Biomedical Announces Cooperation Agreement with 22NW(Globenewswire)
2024-05-15 09:55
ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024(Investorplace)
2024-05-15 01:05
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates(Businesswire)
2024-02-13 03:05
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates(Businesswire)
2023-11-14 03:05
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates(Businesswire)
2023-10-18 21:40
Are Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?(Yahoo Finance)
2023-10-06 04:06
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors(Businesswire)
2023-10-06 04:06
Anebulo Pharmaceuticals Announces New CEO(Businesswire)
2023-10-02 21:40
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?(Yahoo Finance)
2023-09-20 22:06
Enphase Energy upgraded, Brighthouse downgraded: Wall Street's top analyst calls(Yahoo Finance)
2023-09-20 04:29
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates(Yahoo Finance)
2023-08-29 20:00
Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences(Yahoo Finance)
2023-08-21 21:37
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001(Yahoo Finance)
2023-08-20 20:00
Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension(Yahoo Finance)
2023-08-14 22:20
Sidoti Events, LLCs Virtual August Micro-Cap Conference(Yahoo Finance)
2023-06-11 21:40
Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year?(Yahoo Finance)
2023-05-29 20:33
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully(Yahoo Finance)
2023-05-23 21:40
Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year?(Yahoo Finance)
2023-05-18 21:35
Down -26.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Anebulo Pharmaceuticals, Inc. (ANEB)(Yahoo Finance)
2023-05-10 20:00
Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates(Yahoo Finance)
2023-03-27 20:00
Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication(Yahoo Finance)
2023-03-07 19:00
Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions(Yahoo Finance)
2023-02-13 20:30
Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences(Yahoo Finance)
2023-02-09 19:38
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates(Yahoo Finance)
2023-01-08 19:00
Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication(Yahoo Finance)
2022-12-20 16:42
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth(Yahoo Finance)
2022-11-09 19:00
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates(Yahoo Finance)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.